United Therapeutics Corp (UTHR) Company Profile & Statistics

United Therapeutics Corp
UTHR
(Nasdaq - US)
N/A
255.05
+20.72 (+8.84%)
in:usd•As of: May 01, 2024 15:59 UTC -4
Open
244.00
High
258.48
Low
237.52

About United Therapeutics Corp

CEO

Martine Rothblatt

Headquarters

1000 spring st

silver spring, md 20910, united states

Auditor

Ernst & Young LLP

Employees

1,168

Share Holders

Website

www.unither.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.

United Therapeutics Corp Statistics

Valuation Measures

Market Capitalization ²	11.32B
Enterprise Value	10.81B
Enterprise Value/EBITDA (ttm)	8.73
Price to Earnings Ratio (ttm)	12.01
Price to Book (mrq)	1.87
Price to Sales (ttm)	4.82
Price to Cash (ytd)	10.79

Profitability

Gross Margin (ttm)	88.97%
Operating Margin (ttm)	42.31%
Profit Margin (ttm)	42.55%
Return on Equity (ttm)	17.72%
Return on Invested Capital (ttm)	16.00%
Return on Assets (ttm)	14.47%

Income Statement

Revenue (ttm)	2.33B
Revenue Per Share (ttm)	49.46
Gross Profit (ttm)	2.07B
EBITDA (ttm)³	1.24B
Net Income Avi to Common (ttm)	984.80M
Diluted EPS (ttm)	19.84

Share Statistics

Beta (5Y Monthly)	0.52
52-Week Change	11.48%
S&P500 52-Week Change	23.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	47.06M
Dividend Yield	0.00%
Float ⁴	41.18M
% Held by Insiders	12.50%
% Held by Institutions	94.08%

Balance Sheet

Total Cash (mrq)	2.99B
Total Cash Per Share (mrq)	63.63
Total Debt (mrq)	700.00M
Total Debt/Equity (mrq)	11.70%
Current Ratio (mrq)	4.41%
Quick Ratio (mrq)	4.28%
Book Value Per Share (mrq)	127.23

Cash Flow

Operating Cash Flow Per Share (ytd)	19.68
Free Cash Flow (ytd)	747.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

United Therapeutics Corp

Trade With A Regulated Broker